The neuropeptide oxytocin (OT) has been detected in testis and epididy
mis of several mammals. The peptide affects steroidogenesis and sperm
transport in vivo. Effects of OT on sperm motility in vitro seems to b
e contradictory. As no data are available on the presence of OT in hum
an semen and on the relationship of OT with sperm characteristics, we
assessed OT level in semen samples in 3 groups of patients: (I) normoz
oospermic, (II) astheno-/oligo-/teratozoospermic, and (III) azoospermi
c subjects. Furthermore, we studied the relationship between the conce
ntration of OT in semen and the sperm characteristics. OT was measured
in seminal plasma by radioimmunoassay after extraction. OT semen leve
ls did not differ in control patients (I: 1.72 +/- 0.78 pg/mL; n = 10)
, patients with poor semen quality (II: 1.66 +/- 0.91 pg/mL; n = 11),
or in vasectomized patients (III: 1.28 +/- 0.65 pg/mL; n = 11). No sta
tistically significant relationships between the OT levels and sperm c
haracteristics (density: 0.0693; total sperm count: 0.0845; percentage
of motility: 0.1341; morphology: 0.3478) have been found. The neurose
cretory peptide oxytocin is present in human seminal plasma of normal
as well as of vasectomized subjects. OT is not only derived from the t
estis; OT levels in poor semen samples are not different from controls
. No relationship was found between OT seminal plasma levels and sperm
characteristics.